Anxiety and depression symptoms in Brazilian sexual minority ecstasy and LSD users
Lysa Remy, Juliana Nichterwitz Scherer, Luciano Santos Pinto Guimarães, Hilary L. Surratt, Steven P. Kurtz, Flávio Pechansky, Félix Henrique Paim Kessler
Trends in Psychiatry and Psychotherapy November 11, 2017 DOI: 10.1590/2237-6089-2016-0081 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional study Peer reviewed |
|---|---|
| Sample size | 240 |
| Population | Young Brazilian adults who used ecstasy and/or LSD in the past 90 days and were not in treatment for alcohol or drug abuse |
| Topics | Anxiety MDMA Depression LSD |
| Keywords | Depression economics Clinical psychology Substance abuse |
| Citations | 12 |
| Key findings | Depression symptoms in the past 12 months were 37% higher among sexual minority ecstasy and LSD users compared to heterosexual users. |
Abstract
Abstract Background This study examined drug use patterns and psychiatric symptoms of anxiety and depression among young Brazilian sexual minority ecstasy and LSD users and compared findings with those reported for their heterosexual peers.
Method: This cross-sectional study employed targeted sampling and ethnographic mapping approaches via face-to-face interviews conducted at bars and electronic music festivals using an adapted, semi-structured version of the Global Appraisal of Individual Needs questionnaire. The sample comprised 240 male and female young adults who had used ecstasy and/or LSD in the 90 days prior to the interview and who were not on treatment for alcohol and drug abuse.
Results: Of the 240 subjects enrolled (mean age: 22.9±4.5 years), 28.7% were gay or bisexuals. Multivariate regression analysis showed that the prevalence of depression symptoms in the past 12 months in the sexual minority group was 37% higher than among heterosexuals (prevalence ratio [PR]=1.79; 95% confidence interval [95%CI] 1.03-3.11; p=0.037).
Conclusion: Strategies should be developed to assess and address individual needs and treatment approaches should be tailored to address depressive symptoms in young, sexual minority club drug users.